After conducting clinical trials for spinal cord injuries in the US and China, US-based stemcell transplantation and therapeutics company, StemCyte Inc is planning to conduct the same in India next year.
The company has set up an umbilical cord blood public bank for India in a joint venture with Chennai-based Apollo Hospitals and Ahmedabad-based Cadila Pharmaceuticals. Operational by the end of this year, StemCyte India Therapeutics Pvt Ltd, will aid in carrying out clinical trials in India.
“Umbilical cord blood stem cells have become a prime source of stem cells for the field of regenerative medicine for various diseases and our aim is to provide the service of banking cord blood cells to families who want to store stem cells. We are looking at being fully operational by next year in India and will start clinical trials for spinal cord injury here as well. At present, we plan to focus on spinal cord injuries resulting out of an accident or trauma,” said Kenneth Giacin, chairman and CEO of StemCyte Inc.
March 26th, 2010 at 2:24 pm
Hi,
Have you studied the effect of cord blood in spinal cord stroke victims? How far have you come with your research on spinal cord injury announced last August?
My husband had a spinal cord stroke last July and is paralyzed from the waist down. I would think that his injury would be easier to treat than a spinal cord injury caused by trauma.
I look forward to your reply.
Lynn Stedd-White
July 7th, 2010 at 3:43 am
respecte sir,
I am Jagadeesh Munoli. Presently working as a clinical research coordinator and assistant medical writer from august 2009 in International Stemcell Services Limited Bangalore…… in ISSL we are conducting SPINAL CHORD INJURY, osteoarthritis, DMD, CRONICH RENAL FAILURE, LIVER SCLEROSIS CLINICAL TRAILS….and also treating patients
Now I am looking for clinical research job[phamacoigilance or CRA or medical writing or clinops or clinical data managment or regulaory affairs Or In QA/QC].
thNKING YOU
AWAITING FOR POSITIVE RESPONSE
REGARDS;
JAGADEESH